title: Effects of macrophage inducible nitric oxide synthase in murine septic lung injury.
abstract: Inducible nitric oxide synthase (iNOS) contributes importantly to septic pulmonary protein leak in mice with septic acute lung injury (ALI). However, the role of alveolar macrophage (AM) iNOS in septic ALI is not known. Thus we assessed the specific effects of AM iNOS in murine septic ALI through selective AM depletion (via intratracheal instillation of clodronate liposomes) and subsequent AM reconstitution (via intratracheal instillation of donor iNOS+/+ or iNOS-/- AM). Sepsis was induced by cecal ligation and perforation, and ALI was assessed at 4 h: protein leak by the Evans blue (EB) dye method, neutrophil infiltration via myeloperoxidase (MPO) activity, and pulmonary iNOS mRNA expression via RT-PCR. In iNOS+/+ mice, AM depletion attenuated the sepsis-induced increases in pulmonary microvascular protein leak (0.3 +/- 0.1 vs. 1.4 +/- 0.1 microg EB.g lung(-1).min(-1); P < 0.05) and MPO activity (37 +/- 4 vs. 67 +/- 8 U/g lung; P < 0.05) compared with that shown in non-AM-depleted mice. In AM-depleted iNOS+/+ mice, septic pulmonary protein leak was restored by AM reconstitution with iNOS+/+ AM (0.9 +/- 0.3 microg EB.g lung(-1).min(-1)) but not with iNOS-/- donor AM. In iNOS-/- mice, sepsis did not induce pulmonary protein leak or iNOS mRNA expression, despite increased pulmonary MPO activity. However, AM depletion in iNOS-/- mice and subsequent reconstitution with iNOS+/+ donor AM resulted in significant sepsis-induced pulmonary protein leak and iNOS expression. Septic pulmonary MPO levels were similar in all AM-reconstituted groups. Thus septic pulmonary protein leak is absolutely dependent on the presence of functional AM and specifically on iNOS in AM. AM iNOS-dependent pulmonary protein leak was not mediated through changes in pulmonary neutrophil influx.
authors.affiliation: Centrre for Critical Illness Research, Division of Respirology, Department of Medicine, London Health Sciences Center, University of Western Ontario, South St. Campus, 375 South Street, London, Ontario, Canada.
authors.forename: K S
authors.initials: KS
authors.lastname: Farley
authors.forename: L F
authors.initials: LF
authors.lastname: Wang
authors.forename: H M
authors.initials: HM
authors.lastname: Razavi
authors.forename: C
authors.initials: C
authors.lastname: Law
authors.forename: M
authors.initials: M
authors.lastname: Rohan
authors.forename: D G
authors.initials: DG
authors.lastname: McCormack
authors.forename: S
authors.initials: S
authors.lastname: Mehta
mesh_terms: D000818:Animals; D001483:Base Sequence; D004002:Clodronic Acid / Q000494:pharmacology; D017931:DNA Primers; D004195:Disease Models, Animal; D015971:Gene Expression Regulation, Enzymologic; D008171:Lung Diseases / Q000201:enzymology / Q000382:microbiology*; D016676:Macrophages, Alveolar / Q000201:enzymology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D052247:Nitric Oxide Synthase Type II / Q000235:genetics*; D011506:Proteins / Q000378:metabolism; D011652:Pulmonary Circulation / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics; D018805:Sepsis / Q000201:enzymology*
chemical_list: D017931:DNA Primers; D011506:Proteins; D012333:RNA, Messenger; D004002:Clodronic Acid; D052247:Nitric Oxide Synthase Type II